Q3 2021 Holdings
Filed 2021-11-15 | 70 holdings | $181.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $79.7M | 499,824 | 43.8% |
| Align Technology Inc(ALGN) | COMM | 016255101 | $31.3M | 47,000 | 17.2% |
| Abbvie Inc(ABBV) | COMM | 00287Y109 | $29.4M | 272,600 | 16.2% |
| Cytokinetics Inc(CYTK) | COMM | 23282W605 | $15.2M | 426,632 | 8.4% |
| Biogen Inc(BIIB) | COMM | 09062X103 | $9.4M | 33,220 | 5.2% |
| ALX Oncology Holdings Inc(ALXO) | COMM | 00166B105 | $7.9M | 107,220 | 4.4% |
| Celldex Therapeutics, Inc.(CLDX) | COMM | 15117B202 | $7.4M | 137,032 | 4.1% |
| Natera Inc(NTRA) | COMM | 632307104 | $345.8K | 3,102,960 | 0.2% |
| Karuna Therapeutics, Inc. | COMM | 48576A100 | $238.9K | 1,953,077 | 0.1% |
| Aerovate Therapeutics, Inc. | COMM | 008064107 | $78.9K | 3,758,686 | 0.0% |
| AstraZeneca PLC(AZN) | ADR | 046353108 | $67.8K | 1,128,272 | 0.0% |
| Y-mAbs Therapeutics, Inc.(YMABUSD) | COMM | 984241109 | $62.6K | 2,194,278 | 0.0% |
| Vera Therapeutics, Inc.(VERA) | CL A | 92337R101 | $50.6K | 2,914,776 | 0.0% |
| Merck & Co IncCall | CALL | 58933Y905 | $45.1K | 600,000 | 0.0% |
| United Therapeutics Corp(UTHR) | COMM | 91307C102 | $41.0K | 222,094 | 0.0% |
| Bolt Biotherapeutics, Inc.(BOLT1EUR) | COMM | 097702104 | $34.8K | 2,754,437 | 0.0% |
| Galera Therapeutics, Inc.(GRTX) | COMM | 36338D108 | $25.0K | 3,083,712 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COMM | 427746102 | $24.6K | 2,301,179 | 0.0% |
| Bristol-Myers Squibb CoCall | CALL | 110122908 | $23.7K | 400,000 | 0.0% |
| Inozyme Pharma, Inc. | COMM | 45790W108 | $23.5K | 2,028,308 | 0.0% |
| Dexcom Inc(DXCM) | COMM | 252131107 | $20.4K | 37,266 | 0.0% |
| Blueprint Medicines Corp(2L9) | COMM | 09627Y109 | $18.7K | 181,860 | 0.0% |
| Regeneron PharmaceuticalsPut | PUT | 75886F957 | $18.2K | 30,000 | 0.0% |
| Nextcure, Inc | COMM | 65343E108 | $18.0K | 2,671,856 | 0.0% |
| Akouos, Inc. | COMM | 00973J101 | $17.6K | 1,515,074 | 0.0% |
| United Therapeutics CorpPut | PUT | 91307C952 | $17.4K | 94,500 | 0.0% |
| Horizon Therapeutics Pub L | SHS | G46188101 | $17.3K | 157,487 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | COMM | 75615P103 | $15.8K | 157,488 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $14.8K | 4,749,623 | 0.0% |
| Zoetis Inc(ZTS) | CL A | 98978V103 | $14.8K | 76,000 | 0.0% |
| Insmed Inc(INSM) | COMM | 457669307 | $14.7K | 535,120 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | COMM | 803607100 | $14.5K | 157,279 | 0.0% |
| Nucana Plc | ADR | 67022C106 | $14.4K | 5,599,999 | 0.0% |
| Checkmate Pharmaceuticals Inc | COMM | 162818108 | $14.3K | 3,606,707 | 0.0% |
| Kura Oncology Inc(KURA) | COMM | 50127T109 | $14.1K | 755,121 | 0.0% |
| Agenus Inc(AGENEUR) | COMM | 00847G705 | $12.3K | 2,344,410 | 0.0% |
| Zymeworks Inc | COMM | 98985W102 | $11.9K | 410,619 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COMM | 89422G107 | $10.6K | 437,280 | 0.0% |
| Exelixis Inc(EXEL) | COMM | 30161Q104 | $10.3K | 488,414 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COMM | 60468T105 | $10.1K | 56,900 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COMM | 48283N106 | $9.1K | 1,046,312 | 0.0% |
| ChemoCentryx Inc(CCXIEUR) | COMM | 16383L106 | $8.9K | 517,708 | 0.0% |
| ChemoCentryx IncPut | PUT | 16383L956 | $8.6K | 505,800 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMM | 69366J200 | $8.6K | 230,019 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COMM | 46116X101 | $8.5K | 227,419 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COMM | 87164F105 | $7.9K | 413,841 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COMM | 00434H108 | $6.8K | 39,589 | 0.0% |
| Immatics N.v(IMTX) | COMM | N44445109 | $6.2K | 478,216 | 0.0% |
| Nucana Plc | Ordinary Shares | GB00BYWYV | $6.2K | 2,400,000 | 0.0% |
| CTI BioPharma Corp(CTIC1USD) | COMM | 12648L601 | $6.1K | 2,074,714 | 0.0% |